May 3, 2022 | 12-1 p.m. (CT) | Free
Evolution of Platform Vaccine Technologies and the Promise of self-amplifying mRNA for Rapid Response to Emerging Animal Health Diseases
Genvax Co-Founder and CEO, Joel Harris, will cover a high level summary of the founding of Harrisvaccines and eventually exit to Merck Animal Health as well as an introduction to Genvax Technologies and the work towards next generation, rapid response vaccines for animal health.
- Members and Non-Members: Free/$0
Registration for this event is not necessary. Please save the Zoom link below.
Erica Hellmich | 515.294.3104 | email@example.com